---
title: "Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 | VKTX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286085867.md"
description: "Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 | VKTX Stock News"
datetime: "2026-05-12T03:05:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286085867.md)
  - [en](https://longbridge.com/en/news/286085867.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286085867.md)
---

# Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 | VKTX Stock News

Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 | VKTX Stock News

### Related Stocks

- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)

## Related News & Research

- [Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 | VKTX Stock News](https://longbridge.com/en/news/285192819.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [BUZZ-Street View: Skeptical on experimental Alzheimer's drug, awaits full data](https://longbridge.com/en/news/286558948.md)
- [What's Going On With Blackstone Stock Tuesday?](https://longbridge.com/en/news/286894790.md)
- [Stellantis Plan Europe JV With Dongfeng Motor Group For Dongfeng Energy Vehicles](https://longbridge.com/en/news/287024143.md)